[1]
|
Alonso, J., Angermeyer, M.C., Bernert, S., Bruffaerts, R., Brugha, T.S., Bryson, H., et al. (2004) Prevalence of mental disorders in Europe: Results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Supplementum, 420, 21-27.
|
[2]
|
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R. and Walters, E.E. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602.
doi:10.1001/archpsyc.62.6.593
|
[3]
|
Caballero, L., Bobes, J., Vilardaga, I. and Rejas, J. (2009) [Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry outpatient clinics in Spain. Results of the LIGANDO study]. Actas Espa?olas Psiquiatría, 37, 17-20.
|
[4]
|
Chocrón Bentata, L., Vilalta Franch, J., Legazpi Rodríguez, I., Auquer, K. and Franch, L. (1995) Prevalence of psychopathology at a primary care center. Atencion Primaria, 6, 586-590,592-593.
|
[5]
|
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV TR. American Psychiatric Pub, Washington DC.
|
[6]
|
Kessler, R.C. and Wittchen, H.U. (2002) Patterns and correlates of generalized anxiety disorder in community samples. Journal of Clinical Psychiatry, 63, 4-10.
|
[7]
|
Katzman, M.A. (2009) Current considerations in the treatment of generalized anxiety disorder. CNS Drugs, 23, 103-120. doi:10.2165/00023210-200923020-00002
|
[8]
|
McLaughlin, T.P., Khandker, R.K., Kruzikas, D.T. and Tummala, R. (2006) Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization. Journal of Clinical Psychiatry, 67, 1187-1193.
|
[9]
|
Andlin-Sobocki, P. and Wittchen, H.U. (2005) Cost of anxiety disorders in Europe. European Journal of Neurology, 12, 39-44. doi:10.1111/j.1468-1331.2005.01196.x
|
[10]
|
Wittchen, H.U. (2002) Generalized anxiety disorder: Prevalence, burden, and cost to society. Depression and Anxiety, 16, 162-171. doi:10.1002/da.10065
|
[11]
|
Zhu, B., Zhao, Z., Ye, W., Marciniak, M.D. and Swindle, R. (2009) The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder. Journal of Nervous & Mental Disease, 197, 136-139.
doi:10.1097/NMD.0b013e3181963486
|
[12]
|
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, DSM-III. American Psychiatic Association, Washington DC.
|
[13]
|
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, DSM-III-R. American Psychiatric Association, Washington DC.
|
[14]
|
Phillips, K.A. (2009) Report of the DSM-V anxiety, obsessive-compulsive spectrum, posttraumatic, and dissociative disorders work group. American Psychiatric Association, Washington DC.
|
[15]
|
Andrews, G., Hobbs, M.J., Borkovec, T.D., Beesdo, K., Craske, M.G., Heimberg, R.G., Rapee, R.M., Ruscio, A.M. and Stanley, M.A. (2010) Generalized worry disorder: A review of DSM-IV generalized anxiety disorder and options for DSM-V. Depression and Anxiety, 27, 134-147.
doi:10.1002/da.20658
|
[16]
|
Lebeau, R.T., Glenn, D.E., Hanover, L.N., Beesdo-Baum, K., Wittchen, H.U. and Craske, M.G. (2012) A dimensional approach to measuring anxiety for DSM-5. International Journal of Methods in Psychiatric Research, 21, 258-272. doi:10.1002/mpr.1369
|
[17]
|
Angst, J., Gamma, A., Joseph Bienvenu, O., Eaton, W.W., Ajdacic, V., Eich, D. and R?ssler W. (2006) Varying temporal criteria for generalized anxiety disorder: Prevalence and clinical characteristics in a young age cohort. Psychological Medicine, 36, 1283-1292.
doi:10.1017/S0033291706007938
|
[18]
|
Kessler, R.C., Brandenburg, N., Lane, M., Roy-Byrne, P., Stang, P.D., Stein, D.J. and Wittchen, H.U. (2005) Rethinking the duration requirement for generalized anxiety disorder: Evidence from the National Comorbidity Survey Replication. Psychological Medicine, 35, 1073-1082.
doi:10.1017/S0033291705004538
|
[19]
|
Lee, S., Tsang, A., Ruscio, A.M., Haro, J.M., Stein, D.J., Alonso, J., et al. (2009) Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries. Psychological Medicine, 39, 1163-1176. doi:10.1017/S0033291708004807
|
[20]
|
Ruscio, A.M., Chiu, W.T., Roy-Byrne, P., Stang, P.E., Stein, D.J. and Wittchen, H.U. (2007) Broadening the definition of generalized anxiety disorder: Effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders, 21, 662-676.
doi:10.1016/j.janxdis.2006.10.004
|
[21]
|
Carter, R.M., Wittchen, H.U., Pfister, H. and Kessler, R.C. (2001) One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depression and Anxiety, 13, 78-88.
doi:10.1002/da.1020
|
[22]
|
Lee, S., Ma, Y.L., Tsang, A. and Kwok, K. (2009) Generalized anxiety disorder with and without excessive worry in Hong Kong. Depression and Anxiety, 26, 956-961. doi:10.1002/da.20578
|
[23]
|
Lee, S., Tsang, A., Ruscio, A.M., Haro, J.M., Stein, D.J., Alonso, J., Angermeyer, M.C., Bromet, E.J., Demyttenaere, K., de Girolamo, G., de Graaf, R., Gureje, O., Iwata, N., Karam, E.G., Lepine, J.P., Levinson, D., Medina-Mora, M.E., Oakley-Browne, M.A., Posada-Villa, J. and Kessler, R.C. (2009) Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries. Psychological Medicine, 39, 1163-1176. doi:10.1017/S0033291708004807
|
[24]
|
Ruscio, A.M., Lane, M., Roy-Byrne, P., Stang, P.E., Stein, D.J., Wittchen, H.U. and Kessler, R.C. (2005) Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychological Medicine, 35, 1761-1772. doi:10.1017/S0033291705005908
|
[25]
|
Ruscio A.M. (2002) Delimiting the boundaries of generalized anxiety disorder: Differentiating high worriers with and without GAD. Journal of Anxiety Disorders, 16, 377-400. doi:10.1016/S0887-6185(02)00130-5
|
[26]
|
álvarez, E., Carrasco, J.L., Olivares, J.M., Vilardaga, I., López-Gómez, V. and Pérez, M. (2012) Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study. Clinical Practice & Epidemiology in Mental Health, 8, 158-168.
doi:10.2174/1745017901208010158
|
[27]
|
Lobo, A., Chamorro, L., Luque, A., Dal-Ré, R., Badia, X. and Baró, E. (2002) [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales]. Medicina Clinica, 118, 493-499.
|
[28]
|
Consejo General de Colegios Oficiales de Farmacéuticos (2008) Catálogo de especialidades farmacéuticas. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid.
|
[29]
|
Oblikue (2008) eSALUD. Base de datos de costes sanitarios. In: Social, S.C.d.E.e.E.d.l.S.y.P., Ed., SOIKOS, Barcelona.
|
[30]
|
Kazis, L.E., Anderson, J.J. and Meenan, R.F. (1989) Effect sizes for interpreting changes in health status. Medical Care, 27, S178-S189.
doi:10.1097/00005650-198903001-00015
|
[31]
|
Marciniak, M.D., Lage, M.J., Dunayevich, E., Russell, J.M., Bowman, L., Landbloom, R.P., et al. (2005) The cost of treating anxiety: The medical and demographic correlates that impact total medical costs. Depression and Anxiety, 21, 178-184. doi:10.1002/da.20074
|
[32]
|
Olfson, M. and Gameroff, M.J. (2007) Generalized anxiety disorder, somatic pain and health care costs. General Hospital Psychiatry, 29, 310-316.
doi:10.1016/j.genhosppsych.2007.04.004
|
[33]
|
Sicras-Mainar, A., Blanca-Tamayo, M., Navarro-Artieda, R. and Rejas-Gutierrez, J. (2009) Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings. Atención Primaria, 41, 77-84. doi:10.1016/j.aprim.2008.09.008
|
[34]
|
Smit, F., Cuijpers, P., Oostenbrink, J., Batelaan, N., de Graaf, R. and Beekman, A. (2006) Costs of nine common mental disorders: Implications for curative and preventive psychiatry. Journal of Mental Health Policy and Economics, 9, 193-200.
|
[35]
|
Konnopka, A., Leichsenring, F., Leibing, E. and Konig, H.H. (2009) Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. Journal of Affective Disorders, 114, 14-31.
doi:10.1016/j.jad.2008.07.014
|
[36]
|
Lothgren, M. (2004) Economic evidence in anxiety disorders: A review. European Journal of Health Economics, 5, S20-S25. doi:10.1007/s10198-005-0284-3
|
[37]
|
Souêtre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J.M., Adès, J., et al. (1994) Cost of anxiety disorders: impact of comorbidity. Journal of Psychosomatic Research, 38, 151-160. doi:10.1016/0022-3999(94)90145-7
|
[38]
|
Issakidis, C., Sanderson, K., Corry, J., Andrews, G. and Lapsley, H. (2004) Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychological Medicine, 34, 19-35.
doi:10.1017/S003329170300881X
|
[39]
|
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., M?ller, H.J., WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders, Zohar, J., Hollander, E., Kasper, S., Moller, H.J., Bandelow, B., Allgulander, C., Ayuso-Gutierrez, J., Baldwin, D.S., Buenvicius, R., Cassano, G., Fineberg, N., Gabriels, L., Hindmarch, I., Kaiya, H., Klein, D.F., Lader, M., Lecrubier, Y., Lépine, J.P., Liebowitz, M.R., Lopez-Ibor, J.J., Marazziti, D., Miguel, E.C., Oh, K.S., Preter, M., Rupprecht, R., Sato, M., Starcevic, V., Stein, D.J., van Ameringen, M. and Vega, J. (2008) World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders—First revision. World Journal of Biological Psychiatry, 9, 248-312. doi:10.1080/15622970802465807?
|